|
Contracts/ Budgets
Emily Galdes, VP & COO
Tel: (925) 930-7267 x 226
Fax: (925) 930-7392
Email: egaldes@diabloclinical.com
Regulatory
Charlette Vargas
Tel: (925) 930-7267 x 269
Fax: (925) 930-7392
Email: cvargas@diabloclinical.com
New Studies/Recruitment/Marketing/Business Development
Emily Galdes
Tel: (925) 930-7267 x226
Fax: (925) 930-7392
Email: egaldes@diabloclinical.com
Director of Phase 1 Operations
Christine Ramond, FNP, RN, MSN, OCN
Tel: (925) 930-7267 x 321
Fax: (925) 930-7392
Email: craymond@diabloclinical.com
Director of Late Phase Operations
Catherine Morimoto, BS, CCRC
Tel: (925) 930-7267 x 225
Fax: (925) 930-7392
Email: cmorimoto@diabloclinical.com
Executive Director and Investigator
Richard L. Weinstein, MD
Endocrinologist
Tel: (925) 930-7267
Fax: (925) 930-7392
Email: rweinstein@diabloclinical.com
Co-Medical Director and Investigator
Mark P. Christiansen, MD
Endocrinologist
Tel: (925) 930-7267, ext. 255
Fax: (925) 930-7392
Email: mchristiansen@diabloclinical.com
Co-Medical Director and Investigator
Leonard Chuck, MD, PhD
Internist
Tel: (925) 930-7267
Fax: (925) 930-7392
Email: lchuck@diabloclinical.com
Investigator
Lambert, H.K. Chee, MD, FACC
Cardiovascular Specialist
Tel: (925) 930-7267 ext. 255
Fax: (925) 930-7392
Email: lchee@diabloclinical.com
Investigator
Helen Stacey, MD, MPH
Internist
Tel: (925) 930-7267, ext. 255
Fax: (925) 930-7392
Email: hstacey@diabloclinical.com
Investigator
Michael Stein, MD
Neurologist
Tel: (925) 930-7267, ext. 255
Fax: (925) 930-7392
Email: mstein@diabloclinical.com
|
